- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT07705204
Adverse Events Among Hospitalized Patients in China
Adverse Events Among Hospitalized Patients: A Multicenter Evaluation of Four Detection Methods
The goal of this observational study is to learn about the incidence and characteristics of adverse events (AEs) among hospitalized patients in China and to compare 4 commonly used methods for detecting these events. The main questions it aims to answer are:
How common are AEs among hospitalized patients, and what are their characteristics (types, severity, and preventability) in China? How do 4 commonly used methods, including the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs), compare in detecting AEs? Researchers review randomly selected medical records from 5 hospitals in China to identify AEs, assess their type, severity, and preventability, and evaluate the performance of the 4 detection methods.
Обзор исследования
Статус
Условия
Вмешательство/лечение
Тип исследования
Регистрация (Действительный)
Контакты и местонахождение
Места учебы
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Китай, 100730
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Метод выборки
Исследуемая популяция
Описание
Inclusion Criteria:
- age ≥18 years and a length of stay of at least 24 hours
Exclusion Criteria:
- Patients admitted primarily for psychiatric disorders, palliative care, or rehabilitation were excluded.
Учебный план
Как устроено исследование?
Детали дизайна
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Adverse event incidence
Временное ограничение: During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge.
|
The proportion of admissions with at least one adverse event.
|
During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge.
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Types of adverse event
Временное ограничение: During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge
|
During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge
|
|
|
Preventability of adverse event
Временное ограничение: During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge
|
Adverse event with 6-point Likert scale scores ≥4 were considered preventable.
|
During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge
|
|
Severity of adverse events
Временное ограничение: During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge
|
Severity was graded using the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) classification.
|
During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge
|
|
Sensitivity of adverse event detection methods
Временное ограничение: After completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissions
|
Admission-level sensitivity was calculated for the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs).
|
After completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissions
|
|
Specificity of adverse event detection methods
Временное ограничение: After completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissions
|
Admission-level specificity was calculated for the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs).
|
After completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissions
|
|
Positive predictive value (PPV) of adverse event detection methods
Временное ограничение: After completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissions
|
Admission-level positive predictive value (PPV) was calculated for the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs).
|
After completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissions
|
|
Negative predictive value (NPV) of adverse event detection methods
Временное ограничение: After completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissions
|
Admission-level negative predictive value (NPV) was calculated for the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs).
|
After completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissions
|
Соавторы и исследователи
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Действительный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Другие идентификационные номера исследования
- I-25PJ1969
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .